A practical explanation of what imaging changes about hyaluronidase treatment, what it can and can't show, and how to tell whether a practice is genuinely trained in it or simply owns a probe.
This page explains the technique rather than promoting a practice. It is written to be useful whether you are in California or anywhere else — the questions at the end apply to any provider you are considering.
Ultrasound-guided filler dissolving uses high-frequency imaging to see hyaluronic acid filler before and during hyaluronidase injection, so enzyme is placed into the deposit rather than into an estimate of where it might be. It matters most when filler has migrated, has been layered across multiple treatments, is of unknown origin, or sits in a constrained area like the tear trough or nose. For simple, recent, single-session filler, blind dissolving remains reasonable.
A high-frequency linear transducer is placed on the skin over the area of interest. Hyaluronic acid filler is largely anechoic — it appears dark against the surrounding tissue — which makes a discrete deposit reasonably distinguishable from the structures around it.
The operator identifies where deposits sit, at what depth, in which tissue plane, and how extensive they are. Doppler is used to locate vasculature. Hyaluronidase is then injected while the probe remains on the skin, so needle position and enzyme spread are visible during the procedure rather than inferred afterward.
That's the whole technique. It is not complicated in concept. What it requires is a suitable device and someone who can interpret what is on the screen.
Blind dissolving has specific, predictable failure modes. Imaging addresses each of them directly.
None of this changes what hyaluronidase does. The enzyme behaves identically either way. What changes is whether it reaches the right place.
Worth being precise about this, because the technique is sometimes described in terms that overstate it.
Transducer frequency is the specification that counts. Facial soft tissue and superficial filler deposits require a high-frequency linear probe — generally in the 15 to 22 MHz range. Higher frequency gives better resolution at shallow depth, which is exactly what this application needs.
A lower-frequency probe designed for abdominal or obstetric imaging penetrates deeper and resolves less. It will produce an image. It will not reliably distinguish a filler deposit from the tissue around it at two millimetres of depth.
Doppler capability is needed to identify vessels, which is the safety component rather than the targeting one.
Beyond that, handheld and cart-based systems both work. Handheld devices — the Butterfly iQ3 is one commonly used in aesthetics — have made the technique practical in a treatment room rather than requiring a separate imaging suite. That accessibility is much of why the technique has spread.
Handheld devices have become inexpensive enough that many practices now have one. That is straightforwardly good — but it has also made "ultrasound-guided" a marketing phrase that can be adopted without the underlying skill.
Interpreting facial soft tissue sonography is a learned competence. It means recognising tissue planes, distinguishing filler from the several things that resemble it, identifying vessels reliably, and holding a probe steady while injecting with the other hand.
A provider who scans, sees something, and proceeds much as they would have anyway is performing the procedure with an ultrasound in the room rather than performing an ultrasound-guided procedure. The distinction is not visible to the patient, which is why the questions below are worth asking.
These apply anywhere. None of them are hostile, and any practice genuinely using the technique will answer them without hesitation.
An honest limit on the argument. If your filler was placed recently, by a provider who documented the product and volume, in a straightforward location, with no migration and no complication — blind dissolving is entirely reasonable. It has been performed that way successfully for decades.
Guidance earns its place in complex cases: migration, layered treatment across years, unknown filler history, previous incomplete dissolving, anatomically constrained areas such as the tear trough and nose, and any situation where the diagnosis itself is uncertain.
Those cases happen to be most of the ones patients seek help for. But they are not all of them, and a practice presenting imaging as mandatory for every case is overstating it.
Worth noting briefly: ultrasound guidance is also used during filler placement, particularly in high-risk areas such as the nose and tear trough, where identifying vasculature before injecting reduces the risk of intravascular placement.
That application is growing separately from the dissolving one, and a provider trained in one is generally capable of the other. If you are considering filler in an anatomically risky area, it is a reasonable thing to ask about.
The reason I wrote this as a reference rather than a pitch is that most of the people searching for it won't be anywhere near Newport Beach. The technique is spreading, which is good, and the useful thing I can offer someone in London or Chicago is a way to tell whether the practice in front of them is doing it properly. The questions above are the ones I'd ask.
What is ultrasound-guided filler dissolving?
A technique in which high-frequency ultrasound is used to visualise hyaluronic acid filler before and during hyaluronidase injection. The imaging identifies where filler actually sits, its depth and volume, and the position of adjacent blood vessels. Enzyme is then delivered into the identified deposit rather than into an estimated location based on palpation and visual inspection.
Does ultrasound guidance actually improve outcomes?
It addresses specific failure modes of blind technique: filler that has migrated away from the injection site can be located rather than missed, enzyme volume can be reduced because it is targeted, and structures such as vessels can be identified before injection. Its value is greatest where filler has migrated, layered across multiple treatments, or sits in an anatomically constrained area. In simple, recent, single-session cases the advantage is smaller.
What does hyaluronic acid filler look like on ultrasound?
Hyaluronic acid typically appears as a well-defined anechoic or hypoechoic deposit — dark on the image — distinguishable from surrounding tissue. Calcium hydroxylapatite appears markedly different, being highly echogenic with acoustic shadowing. This difference allows imaging to indicate whether a product is likely to respond to hyaluronidase when the filler history is unknown.
What kind of ultrasound is used for filler?
A high-frequency linear transducer, generally in the 15 to 22 MHz range, is required for superficial facial structures. Lower-frequency probes intended for abdominal or obstetric imaging lack the resolution to distinguish filler from surrounding soft tissue at these depths. Doppler capability is used to identify vasculature.
Can ultrasound tell what type of filler I have?
It can distinguish broad categories rather than brands. Hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, and permanent materials such as silicone have characteristically different appearances. Ultrasound cannot identify which specific product was used, but it can indicate whether the material present is likely to respond to hyaluronidase — which is the clinically relevant question.
What are the limitations of ultrasound guidance?
It is operator-dependent — the equipment does not interpret the image. Very small or diffusely distributed deposits can be difficult to resolve. Long-standing filler that has integrated with surrounding tissue may be less distinct. And imaging does not change the biology of hyaluronidase itself. It improves targeting, not the enzyme.
How do I find a provider who offers ultrasound-guided dissolving?
Ask whether imaging is performed during the treatment itself rather than as a separate assessment, what transducer frequency is used, who operates the probe, and whether they can describe what they expect to find before scanning. A practice genuinely using the technique will answer these directly. Owning an ultrasound device and being trained to interpret facial soft tissue imaging are different things.
Is ultrasound guidance necessary for all filler dissolving?
No. For recently placed filler in a straightforward location, with a known product and volume and no migration, blind dissolving is reasonable and has been performed successfully for decades. Guidance provides the most benefit in complex cases: migration, multiple layered treatments, unknown filler history, anatomically constrained areas such as the tear trough and nose, and any case where previous dissolving has been incomplete.
Performed personally by Dr. Amir Mortazavi, MD in Newport Beach — imaging and injection by the same physician, in the same appointment. Patients travel from across Orange County and Los Angeles for correction work and second opinions.
Filler placed at other practices is routinely treated, including where the product and volume are unknown.
General information, not medical advice. This page describes a technique rather than recommending treatment for any individual. Decisions about filler dissolving should be made in consultation with a qualified provider who has examined you. If you are experiencing sudden pain, skin colour change, or vision changes following filler injection, seek urgent medical attention — those can indicate a vascular complication requiring immediate treatment.